mPEG2-N3, namely methyl diethylene glycol azide (1-azido-2-(2-methoxyethoxy)ethane), is a monodisperse, short-chain polyethylene glycol (PEG) derivative. It consists of a methoxy-capped PEG segment composed of 2 ethylene glycol units and a terminal azide group (-N₃), with a single, well-defined molecular weight. Compared to polydisperse PEG, monodisperse PEG offers advantages such as uniform molecular weight, high batch-to-batch reproducibility, and ease of purification and characterization, making it uniquely valuable in molecular design scenarios such as PROTAC synthesis and click chemistry conjugation.

I. Basic Information

II. Structural Features and Mechanism of Action

1. Monodisperse PEG Structure
mPEG2-N3 consists of a defined 2 ethylene glycol repeat units with a single molecular weight. This homogeneity allows for precise study of the impact of PEG chain length on drug pharmacokinetics and pharmacodynamics, avoiding the data ambiguity caused by the molecular weight distribution of polydisperse PEG.

2. Azide Group – The "Connector" for Click Chemistry
The terminal azide group (-N₃) is the core functional site of mPEG2-N3, enabling molecular conjugation through the following pathways:

• Copper-catalyzed Azide-Alkyne Cycloaddition (CuAAC):Reacts specifically with alkyne-containing compounds.

• Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC):Reacts with compounds containing BCN or DBCO groups.

Through these click chemistry reactions, mPEG2-N3 enables covalent conjugation of the PEG chain to proteins, peptides, small-molecule drugs, fluorescent dyes, and nanomaterials.

3. Functional Role of the PEG Chain
The PEG segment imparts excellent water solubility and biocompatibility. Modification of target molecules can improve their aqueous solubility, reduce immunogenicity, and extend in vivo circulation half-life. The short-chain design of 2 ethylene glycol units offers greater flexibility in scenarios where controlled molecular flexibility or reduced steric hindrance is required.

III. Main Applications

1. PROTAC Synthesis
mPEG2-N3 serves as a PEG-based PROTAC linker for the synthesis of PROTAC molecules. PROTACs achieve selective degradation of target proteins by bringing the target protein and E3 ubiquitin ligase into proximity, utilizing the ubiquitin-proteasome system. The short-chain monodisperse structure of mPEG2-N3 makes it an ideal linker for controlling the length and flexibility of PROTAC molecules.

2. Click Chemistry and Bioconjugation
The azide group enables specific conjugation with alkyne-containing biomolecules via click chemistry, facilitating modification of proteins, peptides, and other biomacromolecules.

3. Surface Functionalization of Nanomaterials
mPEG2-N3 can covalently bind to alkyne-modified nanoparticle surfaces through click chemistry, forming stable, biocompatible coatings that reduce nanoparticle aggregation and improve their dispersibility and metabolic behavior in biological systems.

4. Drug Development and Delivery
As a drug modifier, it is used for PEGylation of proteins, peptide compounds, liposomes, and other therapeutics to enhance drug stability and bioavailability.

IV. Related PEG Derivatives